Uric Acid Target for Hypertension: Why 5 mg/dL Matters

Many people know uric acid for its link to gout. Fewer realize it may also play an important role in developing hypertension. Newer studies suggest that 5 mg/dL is the tipping point. Keeping serum uric acid (SUA) below this level could help prevent high blood pressure—especially in those who are otherwise healthy.

Why Focus on 5 mg/dL?

Multiple studies highlight this specific threshold as clinically meaningful. It’s not arbitrary. In fact, 5 mg/dL has emerged as a consistent cutoff across large-scale population data.

For example, Sasaki et al. studied middle-aged and older adults who were either normotensive or normoglycemic. Those with SUA levels at or above 5 mg/dL had a higher incidence of hypertension over time. These individuals were not yet hypertensive, but their elevated SUA seemed to push them in that direction. The findings suggest that managing SUA at an earlier stage could prevent blood pressure issues from developing in the first place [1].

In another study, Wang et al. identified a dose-response relationship between SUA levels and hypertension risk. Risk steadily increased with higher SUA levels, but there was a clear inflection point at 5.079 mg/dL. Above that, the risk rose more steeply. This reinforces the idea that 5 mg/dL is not just a safe target—it’s a meaningful threshold [2].

What About Traditional Hyperuricemia Cutoffs?

Traditionally, hyperuricemia has been defined as SUA ≥6 mg/dL. But that definition may miss early risk signals.

Liu et al. found that even at this higher threshold (≥6 mg/dL), the association with hypertension was significant under both old and new blood pressure definitions—whether ≥140/90 mmHg or the newer ≥130/80 mmHg cutoff [3]. However, by the time SUA reaches 6 mg/dL, vascular changes may already be underway. This underscores the value of acting earlier, before blood pressure rises or damage sets in.

Lifestyle Changes: First-Line Tools

Lowering uric acid doesn’t always require medication. Many people can reach the <5 mg/dL target with personalized lifestyle adjustments. Focus Areas are:

• Reduce purine intake: Cut back on red meat, organ meats, and high-fructose drinks.
• Increase hydration: Water helps flush uric acid from the body.
• Lose excess weight: Obesity increases both uric acid and blood pressure.
• Exercise regularly: Movement improves insulin sensitivity and supports uric acid clearance.

These steps are particularly effective for those with mild elevations and no other metabolic issues.

Medications: When Needed

Lifestyle changes are ideal, but not always enough. Some individuals—especially those with persistent hyperuricemia or added cardiovascular risk—may benefit from pharmacotherapy.

Two main urate-lowering drugs are:

• Allopurinol: It is a xanthine oxidase inhibitor. It works by blocking the enzyme responsible for converting purines into uric acid. As a result, less uric acid is produced in the body. Allopurinol has been used for decades and is often the first choice for long-term uric acid control. It’s generally well tolerated but requires dose adjustments in patients with kidney disease.
• Febuxostat: It is also a xanthine oxidase inhibitor but is structurally different from allopurinol. It provides a more selective and potent inhibition of the enzyme. Febuxostat can be used in patients who are intolerant to allopurinol or those who need stronger uric acid reduction. However, it may carry a slightly higher cardiovascular risk in certain populations, so careful selection and monitoring are important.

These agents can help lower SUA into the target range and may indirectly reduce blood pressure risk as well [4, 5]. Treatment decisions should always be tailored to the individual’s broader health profile.

Interconnected Risks and Individualized Care

Elevated uric acid, hypertension, insulin resistance, and obesity often coexist. Each can worsen the others. That’s why a holistic, personalized approach matters.

Rather than chasing a single number, endocrinologists and hypertension specialists look at the full picture: blood pressure patterns, lab trends, body composition, and lifestyle habits. From this broader view, interventions become more precise—and more effective.

Key Takeaway

A SUA level of 5 mg/dL marks a crucial point in hypertension prevention. Even in people with normal blood pressure and blood sugar, levels above this line predict future risk. Addressing uric acid early—through diet, exercise, or medication—can help prevent long-term complications.

If you’re monitoring your cardiovascular health, don’t overlook uric acid. It may be a small number, but it carries big implications.

Dr. Tashko

---

References:

1. Sasaki N, Ueno Y, Ozono R, et al. Journal of Hypertension. 2024;42(2):292-300. doi:10.1097/HJH.0000000000003597. Association of Serum Uric Acid Levels With Blood Pressure and the Incidence of Hypertension in the Middle-Aged and Elderly Populations.
2. Wang Y, Ouyang Y, Zhang Y. Medicine. 2023;102(38):e34915. doi:10.1097/MD.0000000000034915. Relationship Between Serum Uric Acid and Hypertension in the General US Population Aged 20 Years and Older: A Cross-Sectional Study Based on NHANES 2007 to 2016.
3. Liu YH, Su WY, Lin CY, et al. Journal of Clinical Hypertension (Greenwich, Conn.). 2025;27(2):e70013. doi:10.1111/jch.70013. Impact of Hyperuricemia on Incident Hypertension When Hypertension Definition Changes From 140/­90 to 130/­80 mmHg in a Large Taiwanese Population Follow-Up Study.
4. Gois PHF, Souza ERM. The Cochrane Database of Systematic Reviews. 2020;9:CD008652. doi:10.1002/14651858.CD008652.pub4. Pharmacotherapy for Hyperuricaemia in Hypertensive Patients.
5. Qu LH, Jiang H, Chen JH. Annals of Medicine. 2017;49(2):142-156. doi:10.1080/07853890.2016.1243803. Effect of Uric Acid-Lowering Therapy on Blood Pressure: Systematic Review and Meta-Analysis.